Market Overview:
The global cancer test kits market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer, technological advancements in cancer detection methods, and rising awareness about early diagnosis and treatment of cancer. Based on type, the global cancer test kits market is segmented into blood test, urine test, secretion text, and other tests. The blood test segment is expected to account for the largest share of the global market in 2018. This can be attributed to its high accuracy and easy accessibility. Based on application, the global market is segmented into hematology, endocrine diseases, gastrointestinal diseases infectious diseases,, and other applications.
Product Definition:
Cancer Test Kits are used to detect cancer in a person's body. The test kits can be used to find cancer cells in the blood, urine, or stool.
Blood Test:
A blood test is used to diagnose anemia, infections, inflammation and other diseases. The tests are performed on blood samples taken from a patient's arm or finger. Blood tests are the most common type of medical laboratory tests and account for more than 80% of all clinical chemistry analyzers in use today.
Global Blood Test Market by Product (Reagents & Consumables, Instruments), by Technology (Immunoassay & Chemiluminescence).
Urine Test:
Urine test is used in cancer detection kits to detect the presence of urothelial carcinoma or any other type of urinary tract infection. Urine test is also known as urine analysis or urine sediment analysis. It helps diagnose various conditions such as kidney stones, diabetes, and Chronic Kidney Disease (CKD).
The National Cancer Institute has stated that there are an estimated 14 million new cases of cancer in the U.
Application Insights:
The other application segment includes molecular pathology, cytology and immunochemistry. The growth of the Other segment can be attributed to an increase in demand for rapid testing solutions that are highly specific and sensitive for cancer biomarkers. For instance, liquid biopsy tests have revolutionized oncology by enabling tumor-specific analysis of blood samples taken from patients with various cancers. These types of tests enable physicians to identify the type and degree of a tumor so as to assist them in formulating a treatment plan specific to that type of cancer.
Moreover, increasing research & development investments by major players such as Pathway Genomics PLC; OncoGenex Inc.; Amgen Inc.; Merck KGaA; Pfizer Canada Inc.; Eli Lilly and Company; Roche Ltd.; Astrazeneca GmbH; Bioclinica Mexico SAB de CV; Biodesix LDD CO., LTD.
Regional Analysis:
North America dominated the global cancer test kits market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption rate of advanced diagnostic techniques and a large number of market players in this region. In addition, rising prevalence of cancer is also expected to boost demand for these tests over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to increasing government initiatives for early diagnosis coupled with improving healthcare infrastructure and awareness programs by various NGOs & Public Health Organizations (PHOs). Moreover, economic development in this region will also help boost demand over next eight years due to growing disposable income levels among people diagnosed with cancer as well as their families resulting into higher spending on treatment & care services leading into increased adoption rates for such tests which are subsequently driving regional growth.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the global cancer test kits market. According to the World Health Organization (WHO), in 2012, there were around 14 million new cases of cancer and 8.2 million deaths due to this disease worldwide. This number is expected to increase significantly in the next few years, owing to the aging population and rising prevalence of lifestyle-related diseases such as obesity and smoking. This will create a high demand for accurate and reliable diagnostic tests for early detection and treatment of various types of cancers.
- Technological advancements: The development of novel technologies has led to significant advancements in cancer diagnosis and treatment over the past few years. This has resulted in an increased demand for advanced diagnostic tools such as tumor markers, DNA sequencing, immunohistochemistry (IHC), etc., which are used for detecting various types of cancers at an early stage. Such technological advances are likely to fuel market growth during the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Cancer Test Kits Market Research Report
By Type
Blood Test, Urine Test, Secretion Text, Other
By Application
Hematology, Endocrine Diseases, Gastrointestinal Diseases, Infectious Diseases, Other
By Companies
AB Analitica, Abbott, Alere, Boditech Med Inc., CapitalBio Technology, Chundsell Medicals AB, Elisabeth Pharmacon, ELITech Group, Eurolyser Diagnostica, Gencurix, Inc., HTI Medical Inc., IDL Biotech AB, Litmus Medical Supply, Osang Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
125
Number of Tables & Figures
88
Customization Available
Yes, the report can be customized as per your need.
Global Cancer Test Kits Market Report Segments:
The global Cancer Test Kits market is segmented on the basis of:
Types
Blood Test, Urine Test, Secretion Text, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hematology, Endocrine Diseases, Gastrointestinal Diseases, Infectious Diseases, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AB Analitica
- Abbott
- Alere
- Boditech Med Inc.
- CapitalBio Technology
- Chundsell Medicals AB
- Elisabeth Pharmacon
- ELITech Group
- Eurolyser Diagnostica
- Gencurix, Inc.
- HTI Medical Inc.
- IDL Biotech AB
- Litmus Medical Supply
- Osang Healthcare
Highlights of The Cancer Test Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood Test
- Urine Test
- Secretion Text
- Other
- By Application:
- Hematology
- Endocrine Diseases
- Gastrointestinal Diseases
- Infectious Diseases
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cancer Test Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cancer test kits are a type of home testing kit that can be used to detect the presence of cancer in the body. These kits typically include a variety of tests that can be used to determine if there is any sign or symptom of cancer present.
Some of the major companies in the cancer test kits market are AB Analitica, Abbott, Alere, Boditech Med Inc., CapitalBio Technology, Chundsell Medicals AB, Elisabeth Pharmacon, ELITech Group, Eurolyser Diagnostica, Gencurix, Inc., HTI Medical Inc., IDL Biotech AB, Litmus Medical Supply, Osang Healthcare.
The cancer test kits market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cancer Test Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cancer Test Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cancer Test Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cancer Test Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cancer Test Kits Market Size & Forecast, 2020-2028
4.5.1 Cancer Test Kits Market Size and Y-o-Y Growth
4.5.2 Cancer Test Kits Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Blood Test
5.2.2 Urine Test
5.2.3 Secretion Text
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hematology
6.2.2 Endocrine Diseases
6.2.3 Gastrointestinal Diseases
6.2.4 Infectious Diseases
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cancer Test Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cancer Test Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Blood Test
9.6.2 Urine Test
9.6.3 Secretion Text
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hematology
9.10.2 Endocrine Diseases
9.10.3 Gastrointestinal Diseases
9.10.4 Infectious Diseases
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Blood Test
10.6.2 Urine Test
10.6.3 Secretion Text
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hematology
10.10.2 Endocrine Diseases
10.10.3 Gastrointestinal Diseases
10.10.4 Infectious Diseases
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Blood Test
11.6.2 Urine Test
11.6.3 Secretion Text
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hematology
11.10.2 Endocrine Diseases
11.10.3 Gastrointestinal Diseases
11.10.4 Infectious Diseases
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Blood Test
12.6.2 Urine Test
12.6.3 Secretion Text
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hematology
12.10.2 Endocrine Diseases
12.10.3 Gastrointestinal Diseases
12.10.4 Infectious Diseases
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Blood Test
13.6.2 Urine Test
13.6.3 Secretion Text
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hematology
13.10.2 Endocrine Diseases
13.10.3 Gastrointestinal Diseases
13.10.4 Infectious Diseases
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cancer Test Kits Market: Competitive Dashboard
14.2 Global Cancer Test Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AB Analitica
14.3.2 Abbott
14.3.3 Alere
14.3.4 Boditech Med Inc.
14.3.5 CapitalBio Technology
14.3.6 Chundsell Medicals AB
14.3.7 Elisabeth Pharmacon
14.3.8 ELITech Group
14.3.9 Eurolyser Diagnostica
14.3.10 Gencurix, Inc.
14.3.11 HTI Medical Inc.
14.3.12 IDL Biotech AB
14.3.13 Litmus Medical Supply
14.3.14 Osang Healthcare
